BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 31407777)

  • 21. The effects of smoking on pregnancy risks in women with polycystic ovary syndrome: a population-based study.
    Feferkorn I; Badeghiesh A; Mills G; Baghlaf H; Dahan M
    Hum Reprod; 2021 Aug; 36(9):2549-2557. PubMed ID: 34164665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study.
    Yang HY; Lee HS; Huang WT; Chen MJ; Chen SC; Hsu YH
    J Bone Miner Metab; 2018 Nov; 36(6):741-748. PubMed ID: 29280078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid autoimmunity is associated with higher risk of premature ovarian insufficiency-a nationwide Health Insurance Research Database study.
    Hsieh YT; Ho JYP
    Hum Reprod; 2021 May; 36(6):1621-1629. PubMed ID: 33569594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
    Cooney LG; Lee I; Sammel MD; Dokras A
    Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Aug; 35(8):1914-1921. PubMed ID: 32644124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H; Meng J; Xing H; Nie S; Xu M; Zhang S; Jin Y; Sun T; Huang H; Zhang H; Wang D; Liu L
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a diagnosis of polycystic ovary syndrome on diet, physical activity and contraceptive use in young women: findings from the Australian Longitudinal Study of Women's Health.
    Copp T; Cvejic E; McCaffery K; Hersch J; Doust J; Mol BW; Dokras A; Mishra G; Jansen J
    Hum Reprod; 2020 Feb; 35(2):394-403. PubMed ID: 32003425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study.
    Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Sundström-Poromaa I
    Hum Reprod; 2019 Oct; 34(10):2052-2060. PubMed ID: 31504532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staying up late increases cardiovascular disease risk in women with polycystic ovary syndrome.
    Zeng X; Ye J; Yan X; Zhang J; Guo J; Tao X; Zheng X; Tong M; Huang Y; Zhang M; He C; Chen X; Liu C
    Hum Reprod; 2023 Jul; 38(7):1359-1367. PubMed ID: 37279883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study.
    Kazemi Jaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Hosseinpanah F; Khalili D; Cheraghi L; Azizi F
    Fertil Steril; 2017 Dec; 108(6):1078-1084. PubMed ID: 29202960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study.
    Hung JH; Hu LY; Tsai SJ; Yang AC; Huang MW; Chen PM; Wang SL; Lu T; Shen CC
    PLoS One; 2014; 9(5):e97041. PubMed ID: 24816764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
    Ding T; Hardiman PJ; Petersen I; Baio G
    Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
    Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
    Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome.
    Amer SA; Smith J; Mahran A; Fox P; Fakis A
    Hum Reprod; 2017 Aug; 32(8):1631-1638. PubMed ID: 28854590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.